☆ 4.5 Article

Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis: A Propensity Score Analysis

INFLAMMATORY BOWEL DISEASES (2021)

Get Full Text
Add to Collection

Journal

INFLAMMATORY BOWEL DISEASES
Volume 27, Issue 10, Pages 1694-1697

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izab097

Keywords

ulcerative colitis; comparative effectiveness; biologic therapy; clinical remission; inflammatory bowel disease

Categories

Gastroenterology & Hepatology

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK007533]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.